Literature DB >> 16368828

An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial.

Eugene R Viscusi1, Lowell Reynolds, Stacy Tait, Timothy Melson, Linda E Atkinson.   

Abstract

An iontophoretic fentanyl HCl patient-activated transdermal system (fentanyl HCl PATS) is under development for the treatment of acute postoperative pain. The fentanyl HCl PATS is a needle-free, credit card-sized, preprogrammed system that is applied to the patient's upper outer arm or chest. The fentanyl HCl PATS was demonstrated to be superior to placebo in a previous trial; however, the randomization scheme used and the lack of control of entry pain level may have contributed to the lack of robust findings. We compared the fentanyl HCl PATS with placebo for acute postoperative pain management in a larger trial that addressed the limitations of the previous study. Adult patients admitted to the postanesthesia care unit after major surgery were titrated to comfort with opioids and randomized 1:1 to receive the fentanyl HCl PATS 40 microg or placebo for 24 hours. Supplemental IV fentanyl was available to patients upon request in both treatment groups for the first 3 hours after enrollment. The primary efficacy end-point was the percentage of patients who discontinued participation in the study because of inadequate analgesia. Pain intensity scores, patient global assessments (PGA), and investigator global assessments (IGA) were collected. Four-hundred-eighty-four patients (PATS, n = 244; placebo, n = 240) were enrolled. Fewer patients receiving the fentanyl HCl PATS discontinued because of inadequate analgesia compared with placebo (28.7% versus 60.0%; P < 0.0001). Mean last pain intensity scores were 3.5 and 5.4 for the fentanyl HCl PATS and placebo groups, respectively. Patients (73.4%, PGA) and investigators (72.1%, IGA) considered the fentanyl HCl PATS a good or excellent method of pain control. Treatment-related adverse events were similar between groups. This study demonstrated the superiority of the iontophoretic fentanyl HCl PATS over placebo for acute postoperative pain management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368828     DOI: 10.1213/01.ane.0000183649.58483.77

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

1.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 2.  Analysis of Multiple Routes of Analgesic Administration in the Immediate Postoperative Period: a 10-Year Experience.

Authors:  Nalini Vadivelu; Alice M Kai; Feng Dai; Susan Dabu-Bondoc
Journal:  Curr Pain Headache Rep       Date:  2019-03-11

Review 3.  Fentanyl Formulations in the Management of Pain: An Update.

Authors:  Stephan A Schug; Sonya Ting
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 4.  Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

Review 5.  Recent advances in postoperative pain management.

Authors:  Nalini Vadivelu; Sukanya Mitra; Deepak Narayan
Journal:  Yale J Biol Med       Date:  2010-03

6.  [Postoperative pain management. Application of an iontophoretic patient-activated transdermal system].

Authors:  S Grond; J Jage; H Van Aken
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

7.  Formulations of fentanyl for the management of pain.

Authors:  Sina Grape; Stephan A Schug; Stefan Lauer; Barbara S Schug
Journal:  Drugs       Date:  2010       Impact factor: 9.546

8.  Advances in patient-controlled analgesia: the role of fentanyl ITS.

Authors:  Ian Power; Jon G McCormack
Journal:  Med Devices (Auckl)       Date:  2009-01-12

9.  Acute postoperative pain management: focus on iontophoretic transdermal fentanyl.

Authors:  Consalvo Mattia; Flaminia Coluzzi
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  Transdermal fentanyl patches versus patient-controlled intravenous morphine analgesia for postoperative pain management.

Authors:  Mohamad Hossein Ebrahimzadeh; Seyed Kamal Mousavi; Hami Ashraf; Rahil Abubakri; Ali Birjandinejad
Journal:  Iran Red Crescent Med J       Date:  2014-05-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.